Comirnaty LP.8.1 3 µg/dose · CNK 4969648

Product information

Product name
Comirnaty LP.8.1 3 µg/dose
Pack
10 x 3 doses (0.48 ml)
Active ingredient
CNK Code
4969648
Availability score
0 / 10
Historic availability score
Locked

Product properties

CAS code
ATC code
J07BN01
Company
BioNTech Manufacturing
Pharmaceutical form
Concentrate for dispersion for injection
Ex-factory price
Authorisation number
EU/1/20/1528/050
GTIN
04260703261238
Delivery mode
M1
Delivery environment
Public
CTI Extended
664824-01

Pharmacist Assessment

Assessment title
Commercialization officially ended — no stock
Assessment description

SAM has flagged this product as commercially stopped (reason: Revocation of the authorisation) and no stock is available from wholesalers. Switching to an alternative is necessary.

Assessment no alternative
No available alternative found in the system. Consult the physician for a therapeutic alternative.

Equivalent products

Tier A: Direct equivalents

…

Tier B: Galenic alternatives

…

Tier C: Strength alternatives

…

Tier D: ATC equivalents (parallel import)

…

Tier E: Active substances (magistral)

…

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Active
- present

Revocation of the authorisation

Alternative available

Composition

2 ingredients

Ingredients
Substance Type Strength CAS
Substance
SARS-CoV-2 (Omicron LP.8.1) mRNA
Type
Active ingredient
Strength
3 ug/{dose}
CAS
Substance
Sucrose
Type
Excipient
Strength
CAS

Additional information

Leaflet
Download leaflet
SPC
Download SPC
BCPI
View on BCPI
PharmaStatus
View on PharmaStatus

Availability statistics

Current status
Commercialization stopped
Days unavailable (last year)
119 days
Number of status changes
3
Active supply problems
0
Last change
26/05/2026